[email protected]/(408) 457-3700

About Lyncean Technologies, Inc

Lyncean has commercialized a paradigm shift in X-rays that enables significantly early detection of difficult detect disease like emphysema and breast cancer with 1000x the resolution and 4% radiation dose to the patient than current mammography using CT. 1000x brighter X-rays than leading X-ray/CT devices. 1/100th the size and cost of closest competitor by performance, a synchrotron($B, stadium sized particle collider facilities). First commercial sale commissioned April 2015. $6M sales YTD

You need to register as an accredited investor before we can show you the details of any investment opportunities.

VentureHealth is currently invite only.

Request An Invite!

Startup's Info

Biotechnology, Medical Devices, Diagnostics, Other
Therapeutic Areas: